ABSTRACT Patients with pulmonary sarcoidosis are less likely to smoke than persons of a similar age in the general population. This could be because smoking reduces the likelihood of developing sarcoidosis, or alternatively smoking could reduce the severity of the disease process so that smoking patients are underrepresented among patients with clinically overt disease. To evaluate these possibilities 64 patients with sarcoidosis of recent onset were studied at presentation and after a one year follow up period, clinical, functional, radiographic, and bronchoalveolar lavage fluid criteria being used to identify factors that might account for the lower incidence of sarcoidosis in smokers and to determine whether the disease is less severe in smoking patients. Smoking was less common in the patients with sarcoidosis (30%) than in the control subjects (46%). The study did not support the conclusion that sarcoidosis is less severe in smokers, as clinical, radiographic, and functional abnormalities were similar in smokers and non-smokers at initial evaluation and after a one year follow up period. Nevertheless, smoking did influence various indices used to assess disease "activity." Cigarette smoking was associated with a significant increase in the serum angiotensin converting enzyme activity (SACE), and patients with very high SACE and pulmonary gallium-67 uptake were smokers. Furthermore, more CD8+ (but not CD4+) lymphocytes were recovered by lavage from smoking than from non-smoking patients, giving a lower CD4 :CD8 ratio in smokers. Fewer alveolar macrophages were recovered by lavage from smokers with sarcoidosis than from normal subjects with a similar smoking history. These findings support the possibility that smokers, particularly those with a prominent accumulation of alveolar macrophages in the lower respiratory tract, may be less likely to develop sarcoidosis.
Introduction
Pulmonary sarcoidosis is a granulomatous lung disease in which granuloma formation is preceded by the appearance of an "alveolitis" characterised by increased numbers of T lymphocytes and inflammatory cells.'2 As this immune and inflammatory response develops in situ within the lung, we may reasonably assume that other factors influencing the number and state of activation of immune and inflammatory cells in the lung might alter the initiation or evolution of the alveolitis.
Cigarette smoking is known to produce various alterations in the number, type, and functional activity of lung immune and inflammatory cells. 34 We and others have suggested that the incidence of sarcoidosis is lower among individuals who smoke than among non-smokers, at least in certain subpopulations of patients.>" Two explanations could account for this apparent difference: smoking might reduce the likelihood of developing sarcoidosis, or alternatively it could influence the evolution of the disease so that the signs and symptoms are less severe and therefore smoking patients are underrepresented in series of patients with clinically overt disease.
To evaluate these two possibilities we have studied a homogeneous group of patients with sarcoidosis of recent onset at presentation and after a one year follow up period using clinical, functional, radiographic, and bronchoalveolar lavage fluid indices, to identify Smoking andpulmonary sarcoidosis factors that might account for a lower prevalence of sarcoidosis among cigarette smokers and to determine whether the clinical course of sarcoidosis is less severe in smokers than in non-smokers.
Methods

STUDY POPULATIONS
Patients with sarcoidosis All patients with pulmonary sarcoidosis evaluated at Hopital Avicenne from February 1984 to August 1986 were considered for this study. The diagnosis of pulmonary sarcoidosis was established according to previously described criteria,'2 which included: (1) a compatible clinical picture; (2) presence of noncaseating granulomas in biopsy samples of lung, bronchus, mediastinal nodes, or the site of a KveimSiltzbach reaction: (3) absence of mycobacterial or fungal infections: and (4) absence of exposure to agents known to produce granulomatous disease. For the purpose of this study the duration of disease was regarded as the interval between evaluation and the last normal chest radiograph or since the onset of erythema nodosum.
Among the 133 patients identified, 92 were nonsmokers and 39 were current smokers; only two patients were former smokers and these individuals were excluded from the study. There was no significant difference in mean (SD) age between the two groups (non-smokers 36 (1 1), smokers 32 (12) )y lavage from smoking patients than from The reduced number of alveolar macrophages ng patients. Among smokers the number of recovered from sarcoid smokers compared with con-,es obtained from patients with sarcoidosis trol smokers was not entirely explained by differences ian that recovered from control subjects in tobacco consumption. When control subjects were < 0-001 for control v sarcoidosis group). subdivided according to cigarette consumption the number of macrophages recovered increased progressively as a function ofcigarette consumption (fig 1) . In contrast, only those patients with sarcoidosis who smoked over 20 cigarettes a day had more alveolar macrophages than non-smokers with sarcoidosis, and the total number ofmacrophages recovered from these _ patients with a heavy smoking history was significantly less than that of controls with a similar smoking history (fig 1; p < 0 001 ).
The numbers of lymphocytes recovered/ml lavage fluid in the patients with sarcoidosis was not significantly different in non-smokers and smokers (table 2), nor did smoking modify the total number of CD4+ T lymphocytes recovered by lavage (table 3) .
Smoking, however, was associated with a twofold increase in the number of CD8+ T-lymphocytes recovered (table 3) and as a consequence the CD4: CD8 ratio was significantly lower among smokers than non-smokers with sarcoidosis. In the patients with sarcoidosis there were no cigarette consumption significant differences between smokers and non-(cigarettes /day) smokers in the numbers ofneutrophils, eosinophils, or ber ofalveolar macrophages recovered by mast cells recovered by lavage ( smokers, had higher IgG concentrations in the fluid recovered by bronchoalveolar lavage than the control non-smokers (table 4). As the albumin recovered/ml lavage fluid was similar for control subjects and patients, regardless of their tobacco consumption, the IgG:albumin ratio was higher in patients than in control subjects but similar for non-smoking and smoking patients.
The concentration of IgG in serum was similar for smoking and non-smoking patients with sarcoidosis. When they were considered as a group, the concentration of serum IgG was similar in patients with sarcoidosis and controls. In the sarcoid group, however, 10 522 less likely to smoke than people of a similar age in the general population. The failure to find a significant difference in cigarette consumption between men with sarcoidosis and men in the general population reflects, at least in part, the small number ofpatients evaluated. For example, when the results of the present study (131 patients) are combined with those from a previous study by our group (130 different patients),9 both men and women with sarcoidosis were found to be less likely to smoke than the corresponding groups in the normal population (men: p < 0-02; women: p < 0.001), although the differences for men were not significant for either group when these were considered separately. Only patients with overt pulmonary manifestations, however, were studied and the effect of cigarette smoking, if any, on the incidence of extrathoracic sarcoidosis is unknown. This study was not a case-control study and potential confounding factors such as socioeconomic status and race were not controlled. Our results, however, are concordant with those of several previous studies>" suggesting that the incidence of sarcoidosis is higher in non-smokers than smokers. Nevertheless, not all studies have shown clearly that smoking reduces the incidence of sarcoidosis,23 24 and further studies will be required to explain the differing results so far presented.
THE EFFECT OF CIGARETTE SMOKING ON THE SEVERITY OF SARCOIDOSIS
Our findings do not support the conclusion that the apparent lower incidence of sarcoidosis observed in smokers resulted from the fact that the disease is less severe in these patients. No significant differences were found between smokers and non-smokers in the comparisons of radiographic and functional indices at initial evaluation, and follow up of the two groups did not disclose differences in clinical symptoms, the proportion of patients requiring corticosteroid treatment, or subsequent changes in the results of functional tests or chest radiographs. Although our study did not show major differences in the evolution of lung function in smoking and non-smoking patients studied over one year, we would emphasise that smoking may influence the long term evolution of the disease. For example, Dutton et a125 have shown that residual volume is higher in smokers than nonsmokers with chronic sarcoidosis, and we have confirmed this finding in a small group of patients with sarcoidosis of more than three years' duration (R Georges, unpublished results).
Nevertheless, cigarette consumption did modify some, though not all, indices used in assessing the "activity" of sarcoidosis. Cigarette smoking was associated with a significant increase in SACE activity in sarcoid patients, and all patients with very high Valeyre, Soler, Clerici, Pre, Battesti, Georges, Hance SACE activity and 67Ga accumulation smoked 20 or more cigarettes a day. Gallium uptake26 but not SACE activity2s28 have been reported to be higher in smokers than in non-smokers with sarcoidosis. Both the release of angiotensin converting enzyme and 6"Ga uptake are thought to represent, at least in part, alveolar macrophage activity2829 and presumably relate both to the number of alveolar macrophages present and their state of activation. Cigarette smoking alone, which increases the number of alveolar macrophages considerably, results in only a modest increase in 67Ga uptake and no significant increase in SACE activity.2831' Furthermore, we observed no correlation between the number of alveolar macrophages recovered by lavage and these two indices. These findings suggest that the state of activation of alveolar macrophages is the predominant factor determining the level of these indices. Nevertheless, the increased number of alveolar macrophages that results from smoking in combination with appropriate activation signals (present in some patients with sarcoidosis) may explain the very high 67Ga uptake and SACE activity seen in some, but not all, patients with sarcoidosis who smoked.
Smoking was also associated with a twofold increase in CD8+ T lymphocytes recovered by lavage from patients with sarcoidosis. Similarly, twice as many CD8 + T lymphocytes were observed in smoking as in non-smoking controls, as reported previously.32 As smoking did not affect the recovery of CD4+ T lymphocytes, the CD4: CD8 ratio was significantly lower in smoking than in non-smoking patients, though it was clearly abnormal in almost all patients who smoked.
In this study, like some933 but not all previous studies,34 the number of alveolar macrophages recovered from smoking patients with sarcoidosis was much less than the number recovered from control subjects with a similar smoking history. This finding is consistent with the possibility that smokers who develop a large increase in the number of alveolar macrophages in the lower respiratory tract are unlikely to develop pulmonary sarcoidosis, and might explain in part the lower incidence of sarcoidosis in smokers. In this context, the alveolitis of sarcoidosis is dependent on the proliferation of T lymphocytes within the lung parenchyma,'35 and most previous studies have shown that "excessive" numbers of alveolar macrophages inhibit T lymphocyte proliferation. 3 38 Cigarette smoking is recognised not only as increasing the number of alveolar macrophages in the lung but also as influencing their functional activity. As changes in the number and activity of alveolar macrophages may be associated with each other, our results do not exclude the possibility that changes in
